Evidence map›Paper›PMID 40406541›Full record

ArticleInternational journal of biomaterials2025

Production of Cu

Hashim Hamood Jabbar Al-Gburi, Sayed Ali Hassanzadeh-Tabrizi, Saeid Jabbarzare

Abstract read
In one paragraph

Article in International journal of biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hashim Hamood Jabbar Al-GburiInstitute of Manufacturing Engineering and Industrial Technologies, Na.C, Islamic Azad University, Najafabad, Iran.
Sayed Ali Hassanzadeh-TabriziInstitute of Manufacturing Engineering and Industrial Technologies, Na.C, Islamic Azad University, Najafabad, Iran.ORCID https://orcid.org/0000-0001-8425-4822
Saeid JabbarzareInstitute of Manufacturing Engineering and Industrial Technologies, Na.C, Islamic Azad University, Najafabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a pervasive and devastating disease affecting various parts of the body, posing significant challenges to human societies. Recently, the development of novel magnetic and biocompatible nanoparticles has emerged as a promising approach for magnetic hyperthermia in cancer treatment, complementing existing therapeutic methods. In the present work, Cu

Indexed as

hyperthermiamagnetic propertiesnanostructuressol-gel combustion methodspinel ferrite

Identifiers

PMID40406541
PMCPMC12097855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.